首页> 外文期刊>Cancer science. >Comparative study of one-step nucleic acid amplification assay, frozen section, and touch imprint cytology for intraoperative assessment of breast sentinel lymph node in Chinese patients
【24h】

Comparative study of one-step nucleic acid amplification assay, frozen section, and touch imprint cytology for intraoperative assessment of breast sentinel lymph node in Chinese patients

机译:一步核酸扩增法,冰冻切片和触摸印迹细胞学在中国患者乳房前哨淋巴结术中评估的比较研究

获取原文
           

摘要

Conventional procedures for the intraoperative assessment of breast cancer sentinel lymph nodes (SLNs) are frozen section (FS) and touch imprint cytology (TIC). The one-step nucleic acid amplification (OSNA) assay is a novel molecular technique. The aim of this study was to evaluate the optimal approach by comparing OSNA assay, FS, and TIC. Five hundred and fifty-two consecutive patients were enroled from five study centers in China. The SLNs were cut into alternating 2 mm blocks. The odd blocks were tested by the OSNA assay intraoperatively, and the even ones were assessed by postoperative histology (four 4- to 6-μm-thick sections were taken every 200 μm per block). In addition, intraoperative histological assessments were carried out on the even blocks of 211 patients by FS and all blocks of 552 patients by TIC. Overall performance of the assay compared to postoperative histology was: accuracy 91.4%; sensitivity 83.7%; and specificity 92.9%. The sensitivity of the assay was higher than FS (211 patients, 77.6% vs 69.7%; not significant, P = 0.286) and was significantly higher than TIC (552 patients, 83.6% vs 76.2%; P = 0.044). When assessing nodes with micrometastases, the sensitivity of the assay was higher than FS (17 nodes, 47.1% vs 23.5%; not significant, P = 0.289) and was significantly higher than TIC (48 nodes, 62.5% vs 35.4%; P = 0.007). The study indicated that the OSNA assay is an accurate and rapid intraoperative assay for assessing breast SLNs and it can replace FS and TIC for application in general medical practice. The trial was registered as: OSNA assay China Registration Study. Clinical trial registration number: China Breast Cancer Clinical Study Group 001c.
机译:术中评估乳腺癌前哨淋巴结(SLN)的常规程序是冷冻切片(FS)和触摸印迹细胞学(TIC)。一步式核酸扩增(OSNA)分析是一种新颖的分子技术。这项研究的目的是通过比较OSNA分析,FS和TIC来评估最佳方法。来自中国五个研究中心的542名连续患者入组。将SLN切成交替的2毫米块。术中通过OSNA分析测试奇数块,并通过术后组织学评估偶数块(每块每200μm取4个4至6μm厚的切片)。此外,FS对211例患者进行均匀的术中组织学评估,TIC对552例患者进行均匀的术中组织学评估。与术后组织学相比,该检测的总体性能为:准确度91.4%;敏感度83.7%;特异性为92.9%。该方法的灵敏度高于FS(211例患者,分别为77.6%和69.7%;不显着,P = 0.286),并且显着高于TIC(552例患者,分别为83.6%和76.2%; P = 0.044)。在评估具有微转移的淋巴结时,测定的灵敏度高于FS(17个淋巴结,分别为47.1%vs 23.5%;不显着,P = 0.289),并且显着高于TIC(48个淋巴结,分别为62.5%与35.4%; P = 0.007)。该研究表明,OSNA分析是一种评估乳房SLN的准确,快速的术中分析方法,它可以代替FS和TIC应用于一般医学实践。该试验注册为:OSNA分析中国注册研究。临床试验注册号:中国乳腺癌临床研究组001c。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号